Max Robotics — Global Service Robot Directory + US Certification

About

Ching-Hu Chung is a leading cardiovascular and urologic surgeon-researcher whose work harnesses Taiwan’s National Health Insurance Research Database (NHIRD) to redefine surgical outcomes on a population scale. His core research areas span robotic-assisted surgery, comparative effectiveness, and real-world evidence in minimally invasive procedures. Chung’s major contributions include landmark nationwide cohort studies that directly compare robot-assisted radical prostatectomy (RARP) against open and laparoscopic approaches, as well as robotic-assisted versus conventional sternotomy for mitral valve replacement. By analyzing the entire 2018–2021 NHIRD for prostate cancer surgery and the 2016–2021 dataset for mitral valve procedures, he provides unprecedented, high-powered evidence on perioperative complications, survival rates, and healthcare costs. His work on mid-term outcomes for robotic mitral valve replacement is particularly notable for its propensity-weighted analysis, offering rigorous insights into the trade-offs of advanced surgical technology. Though his most-cited papers are newly published in 2025, their foundation in comprehensive national data positions Chung as a pivotal figure in evidence-based surgical innovation, guiding clinical decision-making and health policy across Taiwan.